Marked benefit with sustained-release niacin therapy in patients with "isolated" very low levels of high-density lipoprotein cholesterol and coronary artery disease

Am J Cardiol. 1992 Apr 15;69(12):1083-5. doi: 10.1016/0002-9149(92)90868-y.

Authors

C J Lavie¹, L Mailander, R V Milani

Affiliation

¹ Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, Louisiana.

PMID: 1561983
DOI: 10.1016/0002-9149(92)90868-y

No abstract available

MeSH terms

Cholesterol, HDL / blood*
Coronary Disease / blood
Coronary Disease / drug therapy*
Delayed-Action Preparations
Humans
Hypertriglyceridemia / drug therapy
Male
Niacin / therapeutic use*

Substances

Cholesterol, HDL
Delayed-Action Preparations
Niacin